About
    Novo Group
    Leadership
    Responsibility
    Novo Nordisk Foundation
  • About
  • Investments
    Areas
    Life Science
    Seed InvestmentsVenture InvestmentsGrowth InvestmentsPrincipal InvestmentsPlanetary Health Investments
    Capital Investments
    Strategy
    Regions
    North AmericaEuropeAsia
    Portfolio
  • Investments
  • People
    Careers
    Open positions
  • People & Careers
  • News & Reports
    Facts & Figures
    Media Library
    Contact Public Relations
  • News & Reports

Naveed Siddiqi

Department

Venture Investments

Position

Senior Partner

Naveed joined Novo Holdings A/S in 2019 and works from London and Copenhagen as a Senior Partner in Venture Investments.

He brings more than 25 years of experience in life science investments and investment banking.  Between 2013 and 2018, he was Partner at Andera Partners, a Paris based venture capital and growth equity firm with over 2 billion euros under management, focusing on life science investing.  He has also worked for Nomura Phase4 Ventures, Nomura International, EFG Corporate Finance, KPMG and as a medical doctor in the UK’s National Health Service.  During his career he has served on multiple European and US boards.  At Novo Holdings he has served on the Boards of Amolyt (acquired by AstraZeneca), Reviral (acquired by Pfizer), Vectivbio (IPO on NASDAQ and acquired by Ironwood), Alentis Therapeutics,  Asceneuron, F2G and Windward Bio. He also served as Board Observer at Numab (sale of Yellow Jersey Therapeutics to J&J).  

Naveed obtained his medical degree from Guy’s and St Thomas’s Hospital Medical School (now King’s College London). Later, he also qualified as a chartered accountant from the Institute of Chartered Accountants England & Wales.

Investing to benefit people and the planet

Novo Holdings A/S

Tuborg Havnevej 19

2900 Hellerup Denmark

+45 3527 6500

Email: Info@novoholdings.dk

CVR# 24257630

Media Relations

Christian Mostrup Scheel

Head of Public Relations

Email: novoholdingsmedia@novo.dk

+45 3067 4805

Novo Holdings US Inc.*

Boston:

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

San Francisco:

One Market Plaza, Floor 17 of the Steuart Tower

San Francisco, CA 94105 USA

+1 (415) 552-6686

Email: Info@novoholdings.dk

Novo Holdings Equity Asia Pte. Ltd.*

#40-01, 6 Battery Road

Singapore 049909

Email: Info@novoholdings.dk

Novo Holdings (UK office)

16 Berkeley Street

London W1J 8DZ

Email: Info@novoholdings.dk

Privacy noticeCode of ConductWhistleblowerArticles of association Policy on data ethicsElectronic invoicingDiversity policy

*Novo Ventures (US) Inc., Novo Holdings US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Follow us